ResearcherHospital de Clínicas de Porto AlegreActive in the last 2 years
Patrícia Ashton-Prolla
Matched on ORCID iD 0000-0002-5093-4739; OpenAlex author ID A5085356021.
Their work
- Papers
- 6 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Mutational signature landscape of pancreatic cancer genomes from nine countries Co-author DOI 10.64898/2026.10.21.26365999↗
- Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Impact. Co-author DOI 10.3390/cancers12071735↗
- miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000000383↗
- H4K12 and H3K18 Acetylation Associates With Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1097/pai.0000000000000194↗
- miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review. Last author DOI 10.4137/bmi.s27679↗
- PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines. Last author DOI 10.1007/s10637-014-0090-9↗
Closest collaborators
The 7 strongest of 7 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Bárbara Alemar · 4 shared papers, 2014–2020
- Paper Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Im… DOI 10.3390/cancers12071735↗
- Paper miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review. DOI 10.4137/bmi.s27679↗
- Paper miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinom… DOI 10.1097/mpa.0000000000000383↗
- Alessandro Bersch Osvaldt · 4 shared papers, 2014–2020
- Paper Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Im… DOI 10.3390/cancers12071735↗
- Paper miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinom… DOI 10.1097/mpa.0000000000000383↗
- Paper H4K12 and H3K18 Acetylation Associates With Poor Prognosis in Pancreatic Cancer. DOI 10.1097/pai.0000000000000194↗
- Cleandra Gregório · 3 shared papers, 2015–2020
- Paper Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Im… DOI 10.3390/cancers12071735↗
- Paper miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review. DOI 10.4137/bmi.s27679↗
- Paper miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinom… DOI 10.1097/mpa.0000000000000383↗
- Patrícia Izetti · 3 shared papers, 2014–2016
- Paper miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinom… DOI 10.1097/mpa.0000000000000383↗
- Paper H4K12 and H3K18 Acetylation Associates With Poor Prognosis in Pancreatic Cancer. DOI 10.1097/pai.0000000000000194↗
- Paper PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer ce… DOI 10.1007/s10637-014-0090-9↗
- Luís Felipe Ribeiro Pinto · 1 shared paper, 2020
- Camila Juliano · 1 shared paper, 2016
- Maria I.Albano Edelweiss · 1 shared paper, 2016
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.